Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression
Cancer and Metastasis Reviews, ISSN: 0167-7659, Vol: 31, Issue: 1-2, Page: 195-208
2012
- 428Citations
- 376Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations428
- Citation Indexes428
- 428
- CrossRef219
- Captures376
- Readers376
- 376
- Mentions1
- News Mentions1
- 1
Most Recent News
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Introduction Nowadays, cancer remains one of the leading causes of death globally, accounting for more than 10 million deaths each year. CAFs has garnered increasing
Review Description
Several recent papers have now provided compelling experimental evidence that the progression of tumours towards a malignant phenotype does not depend exclusively on the cell-autonomous properties of cancer cells themselves but is also deeply influenced by tumour stroma reactivity, thereby undergoing a strict environmental control. Tumour microenvironmental elements include structural components such as the extracellular matrix or hypoxia as well as stromal cells, either resident cells or recruited from circulating precursors, as macrophages and other inflammatory cells, endothelial cells and cancer-associated fibroblasts (CAFs). All these elements synergistically play a specific role in cancer progression. This review summarizes our current knowledge on the role of CAFs in tumour progression, with a particular focus on the biunivocal interplay between CAFs and cancer cells leading to the activation of the epithelial-mesenchymal transition programme and the achievement of stem cell traits, as well as to the metabolic reprogramming of both stromal and cancer cells. Recent advances on the role of CAFs in the preparation of metastatic niche, as well as the controversial origin of CAFs, are discussed in light of the new emerging therapeutic implications of targeting CAFs. © 2011 Springer Science+Business Media, LLC.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862313154&origin=inward; http://dx.doi.org/10.1007/s10555-011-9340-x; http://www.ncbi.nlm.nih.gov/pubmed/22101652; http://link.springer.com/10.1007/s10555-011-9340-x; http://www.springerlink.com/index/10.1007/s10555-011-9340-x; http://www.springerlink.com/index/pdf/10.1007/s10555-011-9340-x; https://dx.doi.org/10.1007/s10555-011-9340-x; https://link.springer.com/article/10.1007/s10555-011-9340-x
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know